收藏!FDA官网使用指南图解

2020-06-12 网络 网络

FDA

本文汇总了新版FDA网站常用数据检索途径,旨在能帮助大家更快使用新版FDA网站,提高文献检索工作效率。

本文汇总了新版FDA网站常用数据检索途径,旨在能帮助大家更快使用新版FDA网站,提高文献检索工作效率。 打开浏览器,输入“FDA”进入或打开链接https://www.fda.gov/,进入FDA主页,如“图1”     图1   点击“图1”中“Drugs”进入药物检索页,网址:https://www.fda.gov/drugs,一般情况从“图2”中“Drug Approvals and Databases”可获取绝大多数FDA公开的原研药品信息。   图2   点击“图2”中的“Drug Approvals and Databases”进入药物批准数据库,网址:https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases。页面如下,进入各数据库列表。   图3   1、  药物检索 点击“图3”中“Drugs @FDA Search”,网址:https://www.accessdata.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=969225, encodeId=d0d8969225e4, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e345509328, createdName=ms3000001222999800, createdTime=Fri May 28 15:22:21 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000083, encodeId=ee201000083a7, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd395550701, createdName=ms9000000379160712, createdTime=Fri Jul 16 17:37:34 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051185, encodeId=eb771051185b3, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:51:19 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892760, encodeId=3203892e6004, content=太实用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1bb5424966, createdName=ms6000001871966411, createdTime=Sun Oct 18 08:14:06 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-05-28 ms3000001222999800

    怎么打不开

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=969225, encodeId=d0d8969225e4, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e345509328, createdName=ms3000001222999800, createdTime=Fri May 28 15:22:21 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000083, encodeId=ee201000083a7, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd395550701, createdName=ms9000000379160712, createdTime=Fri Jul 16 17:37:34 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051185, encodeId=eb771051185b3, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:51:19 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892760, encodeId=3203892e6004, content=太实用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1bb5424966, createdName=ms6000001871966411, createdTime=Sun Oct 18 08:14:06 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-07-16 ms9000000379160712

    怎么打不开

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=969225, encodeId=d0d8969225e4, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e345509328, createdName=ms3000001222999800, createdTime=Fri May 28 15:22:21 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000083, encodeId=ee201000083a7, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd395550701, createdName=ms9000000379160712, createdTime=Fri Jul 16 17:37:34 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051185, encodeId=eb771051185b3, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:51:19 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892760, encodeId=3203892e6004, content=太实用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1bb5424966, createdName=ms6000001871966411, createdTime=Sun Oct 18 08:14:06 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=969225, encodeId=d0d8969225e4, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e345509328, createdName=ms3000001222999800, createdTime=Fri May 28 15:22:21 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000083, encodeId=ee201000083a7, content=怎么打不开, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd395550701, createdName=ms9000000379160712, createdTime=Fri Jul 16 17:37:34 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051185, encodeId=eb771051185b3, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:51:19 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892760, encodeId=3203892e6004, content=太实用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1bb5424966, createdName=ms6000001871966411, createdTime=Sun Oct 18 08:14:06 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2020-10-18 ms6000001871966411

    太实用了

    0

相关资讯

罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权

5月3日,瑞士制药和检测巨头罗氏公司(Roche)宣布,美国食品药品监督管理局(FDA)为其新的Elecsys?Anti-SARS-CoV-2新冠病毒抗体检测技术颁发了紧急使用授权(EUA)。

绿谷制药的阿尔茨海默症新药GV-971,获得FDA批准在美国开展临床试验

GV971去年被NMPA批准用于治疗轻度至中度的阿尔茨海默症,成为自美金刚以来第一种被批准用于该疾病的新药。

4月份,FDA和NMPA批准了哪些新药?

2020年1-4月批准了42个NDA/BLA申请新药,包括5个生物药,12个新分子实体(Type 1),7个新剂型(Type3),5个新组合(Type4),7个新配方或新制造商(Type5),2个已上

FDA批准UroGen的丝裂霉素凝胶Jelmyto,治疗低级别尿路上皮癌

经过优先审查,UroGen Pharma的首个产品Jelmyto用于早期形式的膀胱癌,已获得FDA的批准。

FDA:12项药物被认定为孤儿药资格

最近两周FDA共发出12项孤儿药资格,其中3款为治疗胃癌的在研创新疗法,包括安进(Amgen)公司开发的双特异性抗体。

NASA呼吸机获FDA紧急使用授权,使用寿命3-4个月

由美国国家航空航天局(NASA)开发的呼吸机日前获美国食品和药物管理局(FDA)紧急使用授权,可用于治疗新冠肺炎患者。FDA局长斯蒂芬·哈恩说,“在适当情况下,FDA将继续增